FDA Warning Letter — Fresenius Kabi Oncology Limited
The FDA took a Warning Letter action against Fresenius Kabi Oncology Limited on December 4, 2017 (Nadia, India). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- Fresenius Kabi Oncology Limited
- Date
- December 4, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Nadia (India)